North Bridge Venture Partners & Growth Equity
VC Fund
Wellesley, United States
North Bridge Venture Partners & Growth Equity is a VC fund in Wellesley focused on Software and Enterprise Software. North Bridge provides seed-to-growth stage funding for businesses in several sectors such as software, communications and infrastructure, digital media, healthcare, and material production. North Bridge Venture Partners invests in exceptional people whose ideas have the potential to disrupt the way they live and work. They provide seed-to-growth financing to help transform those ideas into companies and those companies into market leaders.
- Total investments:
- 278
- Last investment:
- Lead investor:
- 34%
- Fund size:
- $580M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries North Bridge Venture Partners & Growth Equity invests in
Stages North Bridge Venture Partners & Growth Equity invests in
Countries North Bridge Venture Partners & Growth Equity invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 16 contacts → | |||
Round size
- Series A
- $5M–$16M
- Series B
- $8M–$37M
- Series C
- $7M–$40M
Investment Focus
Industry
- Software 46 (17%)
- Enterprise Software 27 (10%)
- SaaS 19 (7%)
- Mobile 16 (6%)
- Information Technology 16 (6%)
Stage
- Series B 58 (21%)
- Series C 46 (17%)
- Series A 40 (14%)
- Funding Round 32 (12%)
- Series D 27 (10%)
Country
- United States 122 (44%)
- Canada 2 (1%)
- Israel 2 (1%)
- The Netherlands 2 (1%)
- United Kingdom 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jeff McCarthy
General Partner
|
General Partner | Total investments: 18 | Find email | |
Bill Burgess
Operating Partner
|
Operating Partner | Total investments: 7 | Find email | |
Carmichael Roberts
General Partner
|
General Partner | Total investments: 148 | Find email | |
Christopher E. Cavanagh
Principal
|
Principal | Total investments: 4 | Find email | |
Ed Anderson
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 10 | Find email | |
| See all 16 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently delivermedicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile. | $50M / Post-IPO Equity / May 26, 2023 | ||
| Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently delivermedicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile. | $100.5M / Post-IPO Equity / Apr 08, 2022 | ||
| CubicPV is a solar industry that relies on legacy technologies with inherent limitations. Conventional solar modules convert sunlight to electricity using a single light-absorbing material and are nearing an efficiency threshold. | $25M / Venture - Series Unknown / Jun 28, 2021 | ||
| SmartAsset is an online destination for consumer-focused financial information and advice that powers SmartAdvisor, a national marketplace connecting consumers to financial advisors. Reaching approximately 75 million people each month (as of Sept. 2021) through its educational content and personalized calculators and tools, SmartAsset’s mission isto help people make smart financial decisions. Ranked on the Inc. 5000 list of fastest-growing private companies in 2021, SmartAsset recently closed a $110 million Series D round, valuing the company at over $1 billion. SmartAsset was also named to Y Combinator’s list of Top 100 Companies of all time, 2021 Best Financial Planning Technology Company in New York by Wealth & Finance International, and Forbes’ list of America’s Best Startup Employers in 2020. | $110M / Series D / Jun 24, 2021 | ||
| 24M Technologies develops energy storage systems for grid and transportation applications. It offers binder-free semisolid electrodes and unit cells, eliminating the need for hydro or pyrometallurgical processes for battery recycling. It also helps direct in-plant reuse of active material for end-of-life recycling. | $56.8M / Series E / May 27, 2021 | ||
| Nasuni enables organizations to store, protect, synchronize and collaborate on files across all locations at scale. Nasuni Cloud File Services™, powered by the Nasuni UniFS® global file system, leverages cloud storage to modernize primary NAS and file server storage; archiving; backup; and disaster recovery, while offering transformational newcapabilities for multi-site file sharing. By combining the low cost, unlimited capacity, and durability of object storage from leading cloud vendors such as Amazon, Azure, Dell EMC, and IBM, with the high performance, security, and broad application compatibility of traditional file storage, the Nasuni subscription service improves workforce productivity, simplifies IT operations, and reduces IT costs. The world’s largest companies in 12 industry sectors rely on Nasuni to maximize the business value of their file data and ensure business continuity. | $25M / Private Equity / Jul 14, 2020 | ||
| Couchbase is a NoSQL cloud platform that provides a flexible data management solution for modern applications. It enables developers to efficiently store and retrieve data in JSON format, supporting high-performance operations. The platform offers features such as built-in caching, scalability, and analytics capabilities, allowing organizations tohandle large volumes of data seamlessly. Couchbase also supports various deployment options, including on-premises and cloud environments, catering to diverse business needs. By focusing on ease of use and integration, Couchbase helps teams build applications that require rapid data access and real-time analytics. | $105M / Series G / May 21, 2020 | ||
| Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently delivermedicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile. | $30M / Series C / Jan 29, 2020 | ||
| 1366 Technologies is a manufacturer of silicon wafers used to deliver solar modules. The company's silicon wafers leverage existing billion-dollar cell and module investments, enabling businesses to get a long-term, differentiated product roadmap. It was founded in 2008 and is headquartered in Bedford, Massachusetts. | $18M / Series E / Dec 17, 2019 | ||
| Xtalic offers unique nanostructured metal coatings that provide corrosion resistance, wear resistance and exceptional appearance across a wide range of applications, including decorative and functional metal finishing, as well as electronics. Xtalic's technology delivers premium performance through precisely and dynamically controlling metalstructure at the nanometer scale through a robust electroplating process. Xtalic's coating process is free of hexavalent chromium, reducing environmental compliance costs and worker safety hazards. Xtalic was founded in August of 2005 to commercialize the work of Professor Chris Schuh and Dr. Alan Lund of MIT. | Debt Financing / Oct 01, 2019 | ||
| See all 278 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does North Bridge Venture Partners & Growth Equity invest in?
North Bridge Venture Partners & Growth Equity invests primarily in Software, Enterprise Software and SaaS startups, most often at Series B and Series C stage. Most of the 278 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does North Bridge Venture Partners & Growth Equity invest in?
North Bridge Venture Partners & Growth Equity typically joins rounds of $5M–$16M at Series A, $8M–$37M at Series B and $7M–$40M at Series C. These are whole funding-round sizes, not North Bridge Venture Partners & Growth Equity's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds North Bridge Venture Partners & Growth Equity took part in.
How do I contact North Bridge Venture Partners & Growth Equity?
Public channels for North Bridge Venture Partners & Growth Equity include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at North Bridge Venture Partners & Growth Equity?
The team at North Bridge Venture Partners & Growth Equity includes Jeff McCarthy (General Partner), Bill Burgess (Operating Partner) and Carmichael Roberts (General Partner), among 16 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
